Interest of Flow Cytometry for the Diagnosis, the Follow up and Specific Immunotherapy (SIT) Arrest of Hymenoptera Venom Allergy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-07-31

Study Completion Date

2010-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to show that flow cytometry can be an accurate tool to help physicians regarding the diagnosis, the SIT decision and the SIT arrest of hymenoptera venom allergy.

75 patients having a story of reaction to hymenoptera venom will be selected for this trial.

Blood samples will be analyzed at: inclusion visit, Week 1 visit, Week 3 visit, Week 10 and Week 21 visit.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study if the Presence of Functional FcERI/RII on the Surface of Human Blood Platelet

NCT05848986

Allergy

UNKNOWN

Omalizumab Treatment in Venom Immunotherapy With Systemic Reactions

NCT02968394

Allergy Bee Venom Immunotherapy +1 more

UNKNOWN NA

Omalizumab to Accelerate a Symptom-driven Multi-food OIT

NCT04045301

Food IgE-mediated Allergy Immunotherapy Omalizumab +1 more

ACTIVE_NOT_RECRUITING PHASE2

Treatment of Non Severe Hemophagocytosis Lymphohistiocytosis With ITACITINIB

NCT05063110

Adults Patients Having Non Severe HLH

COMPLETED PHASE2

Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU)

NCT07166211

Chronic Spontaneous Urticaria (CSU)

NOT_YET_RECRUITING PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Allergy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1 flow cytometry

flow cytometry

Group Type EXPERIMENTAL

flow cytometry

Intervention Type OTHER

flow cytometry

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

flow cytometry

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patient (18 - 70 years)
* Patient being informed and accepting to participate in the study with signature of informed consent
* Patients having a clinical systematic and local, loco-regional story of reaction to the piqures of hymenopterans.
* Patients treated by SIT for at least 5 years
* Patients benefiting from a national insurance health

Exclusion Criteria

* Children
* Pregnant woman or who breast-feed
* Patient under antihistaminic or corticoid for less than 8 days before the blood drawing
* Protected Patient
* Patient not having given his agreement after it was informed

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No